Bell J - Search Results

1

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Bell J, Brady MF, Young RC, Lage J, Walker JL, Look KY, Rose GS, Spirtos NM; Gynecologic Oncology Group. Bell J, et al. Gynecol Oncol. 2006 Sep;102(3):432-9. doi: 10.1016/j.ygyno.2006.06.013. Epub 2006 Jul 24. Gynecol Oncol. 2006. PMID: 16860852 Clinical Trial.

2

Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferon.

Markman M, Berek JS, Blessing JA, McGuire WP, Bell J, Homesley HD. Markman M, et al. Among authors: bell j. Gynecol Oncol. 1992 Apr;45(1):3-8. doi: 10.1016/0090-8258(92)90482-x. Gynecol Oncol. 1992. PMID: 1601332 Clinical Trial.

3

5-year survival of patients with periaortic nodal metastases in clinical stage IB and IIA cervical carcinoma.

Lovecchio JL, Averette HE, Donato D, Bell J. Lovecchio JL, et al. Among authors: bell j. Gynecol Oncol. 1989 Jul;34(1):43-5. doi: 10.1016/0090-8258(89)90103-0. Gynecol Oncol. 1989. PMID: 2737524

4

Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.

Bell JG, Minnick A, Reid GC, Judis J, Brownell M. Bell JG, et al. Gynecol Oncol. 1997 Sep;66(3):388-92. doi: 10.1006/gyno.1997.4788. Gynecol Oncol. 1997. PMID: 9299250

5

Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma.

Bell JG, Lea JS, Reid GC. Bell JG, et al. Gynecol Oncol. 2000 May;77(2):314-8. doi: 10.1006/gyno.2000.5790. Gynecol Oncol. 2000. PMID: 10785485

6

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

Rose PG, Brunetto VL, VanLe L, Bell J, Walker JL, Lee RB. Rose PG, et al. Among authors: bell j. Gynecol Oncol. 2000 Aug;78(2):212-6. doi: 10.1006/gyno.2000.5865. Gynecol Oncol. 2000. PMID: 10926805 Clinical Trial.

7

Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.

Thigpen T, Brady MF, Homesley HD, Soper JT, Bell J. Thigpen T, et al. Among authors: bell j. J Clin Oncol. 2001 Jan 15;19(2):364-7. doi: 10.1200/JCO.2001.19.2.364. J Clin Oncol. 2001. PMID: 11208827 Clinical Trial.

8

Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment.

Heddens D, Alberts DS, Hannigan EV, Williams SD, Garcia D, Roe DJ, Bell J, Alvarez RD. Heddens D, et al. Among authors: bell j. Gynecol Oncol. 2002 Sep;86(3):239-43. doi: 10.1006/gyno.2002.6726. Gynecol Oncol. 2002. PMID: 12217742

9

Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study.

Thigpen JT, Blessing JA, Olt G, Lentz SS, Bell J. Thigpen JT, et al. Among authors: bell j. Gynecol Oncol. 2003 Sep;90(3):581-6. doi: 10.1016/s0090-8258(03)00327-5. Gynecol Oncol. 2003. PMID: 13678728 Clinical Trial.

10

Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.

Havrilesky L, Darcy kM, Hamdan H, Priore RL, Leon J, Bell J, Berchuck A; Gynecologic Oncology Group Study. Havrilesky L, et al. Among authors: bell j. J Clin Oncol. 2003 Oct 15;21(20):3814-25. doi: 10.1200/JCO.2003.11.052. J Clin Oncol. 2003. PMID: 14551300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,159 results

Search Page